Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.
Fabbri A., Cossa M., Sonzogni A., Bidoli P., Canova S., Cortinovis D., Abbate M.I., Calabrese F., Nannini N., Lunardi F. et al., 2017/07. Virchows Archiv, 471 (1) pp. 31-47. Peer-reviewed.
ici le détail